Exact Mass: 740.2981186000001

Exact Mass Matches: 740.2981186000001

Found 19 metabolites which its exact mass value is equals to given mass value 740.2981186000001, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Odevixibat

(2S)-2-(((2R)-2-((((3,3-Dibutyl-7-(methylsulfanyl)-1,1-dioxido-5-phenyl-2,3,4,5-tetrahydro-1,2,5-benzothiadiazepin-8-yl)oxy)acetyl)amino)-2-(4-hydroxyphenyl)acetyl)amino)butanoic acid

C37H48N4O8S2 (740.2913408000001)

C78276 - Agent Affecting Digestive System or Metabolism > C177170 - Ileal Bile Acid Transport Inhibitor A - Alimentary tract and metabolism > A05 - Bile and liver therapy > A05A - Bile therapy

(5S)-5-hydroxy-1,7-bis-(4-hydroxyphenyl)-3-heptanone-5-O-[2,6-bis-O-(beta-D-apiofuranosyl)-beta-D-glucopyranoside]

C35H48O17 (740.2891357999999)

2alpha,7beta,9alpha,10beta-13alpha-pentaacetoxy-5alpha-cinnamoyloxy-4beta,20-epoxy-taxa-11-en-1beta-ol

C39H48O14 (740.3043908)

8-methoxyhypophyllanthin-2a-O-beta-apiofuranosyl-(1->6)-O-beta-glucopyranoside

C35H48O17 (740.2891357999999)

Swietephragmin B

C39H48O14 (740.3043908)

7-O-acetyl-5-O-benzoyl-13,15-dihydroxy-3,18-O-dinicotinoyl-14-oxo-lathyrane

C41H44N2O11 (740.2944954000001)

4,4,4-Tris(carbazol-9-yl)-triphenylamine

C54H36N4 (740.2939815999999)

Odevixibat

C37H48N4O8S2 (740.2913408000001)

C78276 - Agent Affecting Digestive System or Metabolism > C177170 - Ileal Bile Acid Transport Inhibitor A - Alimentary tract and metabolism > A05 - Bile and liver therapy > A05A - Bile therapy

(-)-(S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid, hemihydrate

C36H42F2N6O9 (740.2981186000001)

D004791 - Enzyme Inhibitors > D065607 - Cytochrome P-450 Enzyme Inhibitors > D065609 - Cytochrome P-450 CYP1A2 Inhibitors D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D024841 - Fluoroquinolones COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C254 - Anti-Infective Agent > C258 - Antibiotic > C795 - Quinolone Antibiotic Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

Nannochelin C

C36H44N4O13 (740.2904734)

LPIM1 17:4

C32H53O17P (740.3020217999999)

(5r,6r)-9-[(2r,4r,5r,6r)-4-{[(2s,5s,6s)-5-{[(2s,4r,5s,6r)-4,5-dihydroxy-6-methyloxan-2-yl]oxy}-6-methyloxan-2-yl]oxy}-5-hydroxy-6-methyloxan-2-yl]-1,8-dihydroxy-5,6-dimethoxy-3-methyl-5,6-dihydrotetraphene-7,12-dione

(5r,6r)-9-[(2r,4r,5r,6r)-4-{[(2s,5s,6s)-5-{[(2s,4r,5s,6r)-4,5-dihydroxy-6-methyloxan-2-yl]oxy}-6-methyloxan-2-yl]oxy}-5-hydroxy-6-methyloxan-2-yl]-1,8-dihydroxy-5,6-dimethoxy-3-methyl-5,6-dihydrotetraphene-7,12-dione

C39H48O14 (740.3043908)

(2s)-2-{[3-carboxy-3-({[(1s)-1-carboxy-5-[(2e)-n-hydroxy-3-phenylprop-2-enamido]pentyl]-c-hydroxycarbonimidoyl}methyl)-1,3-dihydroxypropylidene]amino}-6-[(2e)-n-hydroxy-3-phenylprop-2-enamido]hexanoic acid

(2s)-2-{[3-carboxy-3-({[(1s)-1-carboxy-5-[(2e)-n-hydroxy-3-phenylprop-2-enamido]pentyl]-c-hydroxycarbonimidoyl}methyl)-1,3-dihydroxypropylidene]amino}-6-[(2e)-n-hydroxy-3-phenylprop-2-enamido]hexanoic acid

C36H44N4O13 (740.2904734)